Healthcare -
Biotechnology - NASDAQ - US
$ 10.88
-0.548 %
$ 594 M
Market Cap
13.27
P/E
STOK - GROSS PROFIT
Gross Profit STOK - Stoke Therapeutics, Inc.
32.1 M
LAST VALUE
90.27%
2 YEAR CAGR
136.10%
5 YEAR CAGR
0.00%
10 YEAR CAGR